Caorui Lin

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The mitochondrial GTPase ERAL1 inhibits HBV replication by triggering the MAVS signaling cascade.

The mitochondrial GTPase ERAL1 inhibits HBV replication by triggering the MAVS signaling cascade.

Journal: Journal of translational medicine

Published: March 26, 2026

Machine learning prediction of functional cure to pegylated interferon-alpha therapy in two HBV populations: Advantaged populations and HBeAg-negative patients.

Machine learning prediction of functional cure to pegylated interferon-alpha therapy in two HBV populations: Advantaged populations and HBeAg-negative patients.

Journal: Virulence

Published: February 09, 2026

The diagnostic value of hepatitis B core-related antigen in occult hepatitis B virus infection and its related hepatocellular carcinoma.

The diagnostic value of hepatitis B core-related antigen in occult hepatitis B virus infection and its related hepatocellular carcinoma.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 21, 2025

Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α.

Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α.

Journal: Gut

Published: January 16, 2025

A novel therapy targeting the gut-liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium.

A novel therapy targeting the gut-liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium.

Journal: JHEP reports : innovation in hepatology

Published: November 01, 2024

Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury.

Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury.

Journal: Gut microbes

Published: February 28, 2024

Characterization of BCP/PreC/C region quasispecies in treatment-naive patients with different phases of HBV infection using next-generation sequencing.

Characterization of BCP/PreC/C region quasispecies in treatment-naive patients with different phases of HBV infection using next-generation sequencing.

Journal: International journal of medical microbiology : IJMM

Published: February 25, 2024

A novel TRIM22 gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis B.

A novel TRIM22 gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis B.

Journal: Microbiology spectrum

Published: October 26, 2023

Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infection.

Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infection.

Journal: Gut

Published: May 31, 2023

Detection of serum large and middle hepatitis B virus surface proteins: A novel potential diagnostic and prognostic biomarker for chronic hepatitis B.

Detection of serum large and middle hepatitis B virus surface proteins: A novel potential diagnostic and prognostic biomarker for chronic hepatitis B.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 21, 2023

Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling.

Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling.

Journal: Cellular and molecular gastroenterology and hepatology

Published: February 13, 2023

Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian.

Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 27, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026